CDXS NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Codexis Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.40 USD
-5.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -29.3% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned -5.4%, after a -43.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 10d.

Setup score 26 out of 100
Latest Close 1.40 USD 31 Jul 2026
1W Return -5.4% latest completed week
4W Return -43.3% short-term follow-through
12W Return -50.9% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Volume is elevated versus the 13-week average, confirming attention.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -5.4% Latest completed week; four-week move -43.3%. Indicator stack 15/13 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 59/100 conviction; expected move 48.2%. News sentiment 49/100 52 relevant articles in the latest sentiment read. Event risk 10d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -29.3% below the Trend Line and sits at 15.2% of its 52-week range. The latest completed week returned -5.4%, after a -43.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5912-week average 0.68

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure9/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.59Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -43.3% over four weeks, -50.9% over 12 weeks, and -48.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-5.4%
4W-43.3%
12W-50.9%
26W12.9%
52W-48.0%
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.64Latest activity-pressure read.
Pressure change-320.3%Four-week change in activity pressure.
Leadership-38.41Latest relative-leadership reading.
RS change-4157.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength6/100Blend of value, momentum, and quality. Underlying universe rank 95; rank 1 is best.
Value28/100Relative valuation strength. Underlying universe rank 73; rank 1 is best.
Quality13/100Profitability and accounting quality. Underlying universe rank 88; rank 1 is best.
Momentum8/100Medium-term price momentum. Underlying universe rank 93; rank 1 is best.
Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.7x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-9.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
83.9%
Gross profit retained from each unit of revenue.
Operating margin
-39.2%
Operating profit retained from revenue.
Free-cash-flow margin
-19.6%
Free cash flow generated from revenue.
Return on invested capital
-29.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
56.8%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-12.8%
Net share repurchases relative to market value.
Shareholder yield
-12.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CDXS shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.08, expected move of 48.2%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move48.2%
Put/call volume0.08
Pressure96
Speculation41
Volatility96
Trend agreement0
Open options detail
Insider activity8 / 1

8 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 52 relevant articles.

8 positive · 32 neutral · 12 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings10dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move48.2%Nearest-chain priced movement where available.
52-week drawdown-63.8%Distance below the 52-week high.
13-week volatility11.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+30.9%Week of 13 Mar.
Worst week-33.9%Week of 24 Jul.
Latest week-5.4%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains4
Flat weeks0
Modest losses4
Sharp losses9
Recent vol11.1%13-week weekly-return volatility.
Base vol11.5%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew7.1% / -8.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis61/100

Latest 12-week confirmation: trend 11/12, activity pressure 9/12, relative leadership 2/12.

Activity pressure 0.59; No reversal markers Factors12/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 88; Small Cap Core rank 75 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

CDXS shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.08, expected move of 48.2%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 48.2% Sentiment49/100

Weighted news tone is neutral across 52 relevant articles.

Codexis, Inc. Revenue Breakdown – BX:4QK Insiders8 / 1

8 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings10d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.40 USD-5.4%1.98 USD2.72 USD-0.64-38.418.4MOff
24 Jul 20261.48 USD-33.9%1.99 USD2.73 USD-0.43-35.6014.0MOn
17 Jul 20262.24 USD-7.8%1.99 USD2.74 USD-0.19-5.892.8MOn
10 Jul 20262.43 USD-1.6%1.97 USD2.75 USD0.07-3.143.2MOn
3 Jul 20262.47 USD3.3%1.95 USD2.76 USD0.29-0.903.9MOn
26 Jun 20262.39 USD-7.0%1.93 USD2.76 USD0.57-4.096.4MOn
19 Jun 20262.57 USD7.1%1.90 USD2.76 USD0.80-2.043.4MOn
12 Jun 20262.40 USD-6.3%1.87 USD2.76 USD0.99-6.533.1MOn
5 Jun 20262.56 USD-7.6%1.84 USD2.76 USD1.131.504.7MOn
29 May 20262.77 USD11.2%1.82 USD2.76 USD1.244.403.1MOn
22 May 20262.49 USD1.2%1.80 USD2.76 USD1.30-3.803.9MOn
15 May 20262.46 USD-13.7%1.81 USD2.76 USD1.40-4.444.8MOn
8 May 20262.85 USD6.7%1.82 USD2.76 USD1.519.608.1MOn
1 May 20262.67 USD1.9%1.81 USD2.76 USD1.527.736.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.